跳至主要内容
临床试验/EUCTR2021-000683-30-SE
EUCTR2021-000683-30-SE进行中(未招募)1 期

CoVacc - Immune response to vaccination against Covid-19, an open multicenter phase IV study

meå university0 个研究点目标入组 3,000 人开始时间: 2021年2月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
3,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Consents to participate in the study
  • Age = 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 2250
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 750

排除标准

  • Age <18 years
  • Incapable of giving informed consent (does not apply to participants in the elderly study)
  • Contraindication to vaccination
  • Severe disease (assessed to affect the subjects ability to complete the study)
  • Ongoing treatment that is judged to affect the vaccine response (Does not include inhaled steroids and nasal sprays, as well as tablet cortisone =15mg / day. Rituximab treatment is not an exclusion criterion.)
  • Participants in the elderly study:
  • The exclusion criteria described in the protocol above for CoVacc will not apply to the sub-study called The Elderly Study, this clinical research study in which people with severe illness and people who lack their own decision-making ability can be included. Data on chronic diseases or drugs will not be collected

研究者

发起方
meå university

相似试验